Factors associated with pregabalin dispensing at higher than the approved maximum dose-Reference-Cited by-同舟云学术

Factors associated with pregabalin dispensing at higher than the approved maximum dose

Published:2013-10-19 Issue:2 Volume:70 Page:197-204
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Bodén Robert,Wettermark Björn,Brandt Lena,Kieler Helle

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-013-1594-5.pdf

Reference26 articles.

1. Tassone DM, Boyce E, Guyer J, Nuzum D (2007) Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther 29:26–48

2. European Medicines Agency (2010). Summary of product characteristics for pregabalin. Available at: http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf . Accessed 28 May 2013

3. Food and Drug Administration (2012) Food and Drug Administration’s Guidance on pregabalin. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf . Accessed 28 May 2013

4. Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin: The calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137–150

5. Bandelow B, Wedekind D, Leon T (2007) Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev Neurother 7:769–781

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study;CNS Drugs;2024-01-25

2. Misuse of Pregabalin: a qualitative study from a patient’s perspective;BMC Public Health;2023-07-12

3. Non-opioid antinociceptive drugs : risk of respiratory depression and death related to concomitant use of gabapentinoids in addition to opioids;Expert Opinion on Drug Safety;2023-03-04

4. Patterns of pregabalin prescribing in four German federal states: analysis of routine data to investigate potential misuse of pregabalin;BMJ Open;2022-07

5. Misuse of gabapentinoids (pregabalin and gabapentin) in patients with neuropathic pain related to spinal cord injury;The Journal of Spinal Cord Medicine;2022-02-02